Isomorphic’s $600M funding among four megarounds: Finance Report

However difficult the biotech funding environment may be at the moment, some ambitious companies are continuing to raise megarounds. This week, four companies announced nine-digit fundings, raising a total of more than $1 billion.

The lion’s share went to Isomorphic Labs Ltd., the London-headquartered spinout of the Google DeepMind unit of Alphabet Inc. (NASDAQ:GOOG) that is advancing an artificial intelligence-guided drug discovery and design engine. Thrive Capital led the $600 million round, which was Isomorphic’s first external funding; GV also participated, as did Alphabet...